Press release
Global Valganciclovir Market Top Leading Players with Strategies and Forecast 2028
The global valganciclovir market is anticipated to grow at a considerable CAGR of 4.9% during the forecast period (2022-2028). Valganciclovir is an antiviral drug used for the treatment of cytomegalovirus in patients suffering from HIV/AIDS or after the procedure of organ transplant. The medication is taken for a long duration as it only suppresses the virus without curing it. The major factor attributing to the growth of the global valganciclovir market is the increasing prevalence of HIV/AIDS across the globe. According to a report published by the World Health Organisation (WHO), the major global public health issue is considered to be HIV/AIDS affecting around 37.7 million people at the end of 2020. Among these, 2/3 of the people are from the African region. The recorded mortality due to HIV/AIDS is around 6,80,000 people. HIV/AIDS has no cure, it can only be prevented or taken care of through various medications such as valganciclovir in the long term for healthy living.Furthermore, the increasing number of organ transplant procedures are also increasing the infection of cytomegalovirus in patients. Thus, increasing the demand for valganciclovir drugs for the treatment of cytomegalovirus. According to the Health Resources & Services Administration (HRSA), more than 40,000 organ transplant procedures are done in 2021 with around 1,06,204 people including men, women, and children on the national transplant waiting list. A person is added to the transplant waiting list every 9 minutes. In addition, several developments are done in the valganciclovir drug for better application. For instance, in December 2021, valganciclovir and nanatinostat got the orphan drug designation from the Food and Drug Administration (FDA) for the treatment of Epstein Barr virus-positive diffuse large B-cell lymphoma. There are two phase 2 clinical trials going on by Viracta Therapeutics for testing the efficacy of valganciclovir on Epstein Barr virus.
The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2020, Entero Healthcare Solutions done an agreement with Roche Products (India) Pvt. Ltd. for the distribution of Roche's nephrology drugs, including valganciclovir (Valcyte). Roche's Valcyte is now distributed by Entero Healthcare Solutions in India.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Valganciclovir Market at:
https://orionmarketreports.com/request-sample/?id=96394&submit=Request+Sample%0D%0A
Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Dosage Form
o By Application
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- F. Hoffmann-La Roche Ltd., Cipla Ltd., Jolly Health Care, Genetech, Inc., and Anthem Biosciences Pvt. Ltd., among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
A full report of Global Valganciclovir Market is available at:
https://orionmarketreports.com/global-valganciclovir-market/96394/
Global Valganciclovir Market Report by Segment
By Dosage Form
• Tablets
• Powder
By Application
• HIV/AIDS
• Organ Transplant
By Distribution Channel
• Hospital Pharmacies
• Retail Drug Stores
Global Valganciclovir Market Report by Region
North America
• The United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Valganciclovir Market Top Leading Players with Strategies and Forecast 2028 here
News-ID: 2596790 • Views: …
More Releases from Orion Market Reports
Module Power Supply Market to see Huge Growth by 2031
The Module Power Supply Market is experiencing substantial growth, fueled by increasing demand for efficient, compact, and reliable power solutions across a wide range of industries. These power supplies, which convert electrical power to a suitable form for specific applications, are essential in sectors like telecommunications, automotive, medical devices, and consumer electronics. With technological advancements and rising energy efficiency needs, the market is expected to continue expanding, driven by innovations…
Plasma Spray Guns Market to see Rapid Growth by 2031
The Plasma Spray Guns Market is witnessing significant growth, driven by the rising demand for surface coating and thermal spray applications across industries such as aerospace, automotive, manufacturing, and electronics. Plasma spray guns are widely used for depositing coatings on substrates to enhance their properties, including wear resistance, corrosion resistance, and thermal protection. As industries continue to focus on improving product performance and durability, the plasma spray gun market is…
Plasma Surface Treatment Machine Market Will Generate Record Revenue by 2031
The Plasma Surface Treatment Machine Market is witnessing significant growth as industries increasingly adopt plasma surface treatment technology for enhancing the properties of materials. Plasma surface treatment machines are used to modify the surface characteristics of materials like metals, plastics, and ceramics, offering improvements in adhesion, corrosion resistance, and wear resistance. As the demand for advanced surface treatments rises across automotive, electronics, packaging, and manufacturing sectors, the market for plasma…
Plasma Torch Market Value Projected to Expand by 2031
The Plasma Torch Market is experiencing rapid growth, driven by the increasing demand for high-precision cutting and welding technologies in industries such as manufacturing, automotive, aerospace, and construction. Plasma torches are essential tools in thermal cutting applications, offering fast and accurate cuts on various materials, including metals, plastics, and composites. With advancements in plasma cutting technology and the growing need for energy-efficient solutions, the market for plasma torches continues to…
More Releases for HIV/AIDS
Global HIV & AIDS Testing Market Insights, Forecast
The global HIV & AIDS Testing market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the HIV & AIDS Testing market based on company, product type, end user and key regions. This report studies the global market size of HIV…
Global HIV-AIDS Testing Market
The HIV-AIDS Testing Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that…
World conference on STDs, STIs & HIV/AIDS
"World Conference on STDs, STIs & HIV/AIDS is a leading Conference in Canada, the program will explore new scientific knowledge and provides a platform for professionals and community members to participate in a structured dialogue on the major issues. The main objective will be to share scientific discoveries and clinical care on HIV and STDs, HIV diagnosis and therapy that would comprise various methods to diagnose HIV, HIV drug discovery,…
Experts Prepare the HIV AIDS 2012 Conference
The world leading AIDS experts will gather for the 2012 ISHEID conference in Marseille, France, May 23-25, 2012. Meanwhile, interviews of leaders in the field are published monthly on the conference website http://www.isheid.com/en/committees/interviews.html.
Neuilly-sur-Seine, France, May 09, 2011 -- The International HIV AIDS ISHEID (International Symposium on HIV & Emerging Infectious Diseases) is the leading biennial conference in the field held in France. It usually attracts more than 1,200 participants from…
HIV AIDS 2012 Conference Preparations Underway
The International HIV AIDS ISHEID (International Symposium on HIV & Emerging Infectious Diseases) organizers offer program information for the May 2012 Conference in Marseille, France.
Neuilly-sur-Seine, France, May 08, 2011 -- The Organizers of the 2012 International HIV AIDS ISHEID (International Symposium on HIV & Emerging Infectious Diseases) and Alain Lafeuillade Chairman, are pleased to announce the topics for the 2012 conference to be held in Marseille, France. The symposium is…
International HIV AIDS 2012 Conference Topics
Neuilly-sur-Seine, France, April 26, 2011 -- The main theme of the 2012 HIV AIDS ISHEID Conference has just been announced: 'From HIV Testing to Cure'. This biennial international AIDS conference will take place next time in Marseille, France, May 23-25, 2012.
“Despite major advances in the past 25 years, HIV infection remains a global threat with major scientific, societal and human challenges ahead”, declared Alain Lafeuillade, chair of the meeting. This…
